Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-01-04 to 2022-01-05
Current total value of award: $725.3
Description: 4555899896!ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML